Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03718364

Swiss Atrial Fibrillation Pulmonary Vein Isolation Registry

Registry of patients with atrial fibrillation undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) to determine long-term success rates of catheter-based ablation of atrial fibrillation (pulmonary vein isolation) and to evaluate factors associated with long-term success of catheter-based ablation of atrial fibrillation (pulmonary vein isolation).

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Cardiology/Electrophysiology, University Hospital Basel, Basel, Switzerland

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation)

Exclusion criteria

  • Patients not able or willing to participate in this study

Treatment and study plan

catheter-based ablation of atrial fibrillation (pulmonary vein isolation)

Procedure

catheter-based ablation of atrial fibrillation (pulmonary vein isolation)

Primary outcomes

  1. changes in retention rate of normal sinus rhythm after catheter-based ablation of atrial fibrillation (pulmonary vein isolation)

    Time frame: before catheter-based ablation of atrial fibrillation and 3, 6 and 12 months after catheter-based ablation of atrial fibrillation

    changes in retention rate of normal sinus rhythm after catheter-based ablation of atrial fibrillation (pulmonary vein isolation)

Secondary outcomes

  1. morphologic changes of left cardiac atrium

    Time frame: before catheter-based ablation of atrial fibrillation (pulmonary vein isolation)

    echocardiography of left cardiac atrium

  2. changes in retention rate of normal sinus rhythm after catheter-based ablation of atrial fibrillation (pulmonary vein isolation)

    Time frame: 12 months after catheter-based ablation of atrial fibrillation and then at intervals of one year until 2035

    changes in retention rate of normal sinus rhythm after catheter-based ablation of atrial fibrillation (pulmonary vein isolation)

Other outcomes

  1. determination of factors associated with long-term success rates of catheter-based ablation of atrial fibrillation

    Time frame: Blood samples gained during catheter-based ablation of atrial fibrillation (pulmonary vein isolation)

    Blood samples (biobanking) for determination of factors associated with long-term success rates of catheter-based ablation of atrial fibrillation (pulmonary vein isolation). Decisions about future analyses to be performed from stored samples will be based exclusively on scientific reasons.

Study contacts

Contact information is provided by the study sponsor or research team.

Gian Voellmin, MSc

CONTACT

[email protected]

+41 61 556 52 96

Michael Kuehne, MD

CONTACT

[email protected]

+41 61 328 74 71

Sponsors and collaborators

Lead sponsor

University Hospital, Basel, Switzerland

Other

Registry information

Acronym: SWISS-AF-PVI)

Important dates

Study start
2010
Primary completion
2035
Study completion
2035
First posted
Oct 24, 2018
Registry last updated
Feb 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.